NEXT SCIENCE LIMITED - Announcements

Market Cap $94.80M Add to my watchlist

Healthcare Medical Instruments & Supplies

Next Science Limited is an Australia-based medical technology company. The Company’s... Next Science Limited is an Australia-based medical technology company. The Company’s primary focus is on the development and commercialization of its proprietary XBIO technology to reduce the impact of biofilm-based infections on human health. XBIO is a non-toxic technology with an efficacy in eradicating both biofilm-based and free-floating bacteria. The Company’s products include XPERIENCE, Blast X, SurgX and Bactisure. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SurgX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel with sustained effectiveness for up to five days. BLASTX Antimicrobial Wound Gel provides wound management by maintaining a moist wound environment, which is conducive to wound healing.More

Announcements

Filter Results

All Price Sensitive Only

NXS	Investor presentation		30/04/24	956.25KB	Share
NXS	Appendix 4C & Quarterly Activity Report - 31 March 2024	PRICE SENSITIVE	24/04/24	409.47KB	Share
NXS	Notice of 1Q FY24 Result and Investor Webinar		22/04/24	123.15KB	Share
NXS	Publication of Dr. Harris XPERIENCE study	PRICE SENSITIVE	18/04/24	170.21KB	Share
NXS	Preliminary results of further XPERIENCE studies released	PRICE SENSITIVE	17/04/24	172.43KB	Share
NXS	Study published showing impact of XPERIENCE on SSIs	PRICE SENSITIVE	16/04/24	168.16KB	Share
NXS	Publication of study showing BLASTX increases NPWT efficacy	PRICE SENSITIVE	09/04/24	185.13KB	Share
NXS	Appendix 4G & 2024 Corporate Governance Statement		05/04/24	641.02KB	Share
NXS	2023 Annual Report		05/04/24	5.25MB	Share
NXS	Notification of cessation of securities - NXS		04/04/24	12.81KB	Share
NXS	2024 AGM - Notice of Meeting		03/04/24	1.86MB	Share
NXS	Board Changes		03/04/24	158.74KB	Share
NXS	2024 Annual General Meeting - Notification of dates		04/03/24	117.85KB	Share
NXS	FY23 Annual Result Investor Presentation	PRICE SENSITIVE	28/02/24	1.02MB	Share
NXS	Next Science reports FY23 Result	PRICE SENSITIVE	28/02/24	186.4KB	Share
NXS	Appendix 4E / FY23 Financial Statements	PRICE SENSITIVE	28/02/24	1.14MB	Share
NXS	Revised Securities Trading Policy		27/02/24	278.34KB	Share
NXS	Notice of FY23 Results and Investor Webinar		16/02/24	125.03KB	Share
NXS	Appendix 4C & Quarterly Activity Report - 31 December 2023	PRICE SENSITIVE	30/01/24	324.86KB	Share
NXS	Vale Lang Walker AO		29/01/24	173.33KB	Share
NXS	Notification of cessation of securities - NXS		12/01/24	21.57KB	Share
NXS	Notification of cessation of securities - NXS		12/01/24	21.52KB	Share
NXS	XPERIENCE study findings published	PRICE SENSITIVE	22/12/23	168.05KB	Share
NXS	Appendix 3Y - A Stockburger		19/12/23	158.78KB	Share
NXS	Appendix 3Y - D Spira		19/12/23	158.8KB	Share
NXS	Notification of cessation of securities - NXS		19/12/23	21.57KB	Share
NXS	Notification of cessation of securities - NXS		19/12/23	21.51KB	Share
NXS	Notification of cessation of securities - NXS		08/12/23	22.63KB	Share
NXS	NXS Presentation - Bell Potter Healthcare Conference		15/11/23	743.41KB	Share
NXS	Response to ASX Aware Letter	PRICE SENSITIVE	07/11/23	785.32KB	Share
NXS	XPERIENCE study findings released	PRICE SENSITIVE	03/11/23	179.47KB	Share
NXS	Appendix 3Y - I.V. Hall		02/11/23	204.51KB	Share
NXS	Appendix 3Y - G Hummel		02/11/23	158.66KB	Share
NXS	Appendix 3Y - A Stockburger		02/11/23	158.96KB	Share
NXS	Change in substantial holding		02/11/23	347.48KB	Share
NXS	Cleansing notice		01/11/23	127.49KB	Share
NXS	Application for quotation of securities - NXS		31/10/23	25.38KB	Share
NXS	Application for quotation of securities - NXS		31/10/23	23.3KB	Share
NXS	Application for quotation of securities - NXS		31/10/23	23.62KB	Share
NXS	NXS Presentation - Wilsons Drug & Device Conference		26/10/23	740.01KB	Share
NXS	General Meeting - Voting Results		25/10/23	215.89KB	Share
NXS	General Meeting - CEO 90 Day Update		25/10/23	226.84KB	Share
NXS	Appendix 3X - Kathy Ostin		24/10/23	180.1KB	Share
NXS	Appointment of new Director		24/10/23	123.01KB	Share
NXS	Investor Presentation - Q3 2023	PRICE SENSITIVE	23/10/23	618.81KB	Share
NXS	Quarterly Activity Report - 30 September 2023	PRICE SENSITIVE	23/10/23	176.67KB	Share
NXS	Appendix 4C - 30 September 2023	PRICE SENSITIVE	23/10/23	261.2KB	Share
NXS	Change in substantial holding		26/09/23	359.95KB	Share
NXS	Cleansing notice		25/09/23	117.69KB	Share
NXS	Notice of General Meeting		22/09/23	1.29MB	Share
NXS	Application for quotation of securities - NXS		22/09/23	23.49KB	Share
NXS	Application for quotation of securities - NXS		22/09/23	23.43KB	Share
NXS	Successful completion of Share Purchase Plan & US Offer	PRICE SENSITIVE	22/09/23	165.12KB	Share
NXS	Becoming a substantial holder		20/09/23	153.19KB	Share
NXS	Becoming a substantial holder from TEK		20/09/23	179.19KB	Share
NXS	Next Science SPP - ASX grants waiver		07/09/23	181.58KB	Share
NXS	Cleansing Notice		06/09/23	117.52KB	Share
NXS	Application for quotation of securities - NXS		05/09/23	23.57KB	Share
NXS	Next Science SPP - Letter to Eligible Shareholders		01/09/23	143.26KB	Share
NXS	Next Science Share Purchase Plan Booklet		01/09/23	236.16KB	Share
NXS	Next Science SPP Offer Opens		01/09/23	138.94KB	Share
NXS	Half Year Results & Capital Raise Presentation	PRICE SENSITIVE	31/08/23	2.29MB	Share
NXS	Cleansing Notice		31/08/23	145.18KB	Share
NXS	Proposed issue of securities - NXS		31/08/23	36.42KB	Share
NXS	Half Year Report & Appendix 4D	PRICE SENSITIVE	31/08/23	557.76KB	Share
NXS	Half Year Results & Capital Raise Update	PRICE SENSITIVE	31/08/23	271.48KB	Share
NXS	Trading Halt	PRICE SENSITIVE	29/08/23	138.39KB	Share
NXS	Appendix 3Z - M Compton		29/08/23	129.75KB	Share
NXS	Appendix 3X - Grant Hummel		28/08/23	180.07KB	Share
NXS	Half Year Results Investor Briefing		25/08/23	171.42KB	Share
NXS	Board Changes		23/08/23	129.37KB	Share
NXS	Potential Anti-Inflammatory Benefit For XPERIENCE	PRICE SENSITIVE	09/08/23	194.97KB	Share
NXS	Investor Presentation	PRICE SENSITIVE	08/08/23	1.46MB	Share
NXS	Notification regarding unquoted securities - NXS		31/07/23	27.25KB	Share
NXS	Notification regarding unquoted securities - NXS		31/07/23	25.54KB	Share
NXS	Appendix 3Z - Judith Mitchell		31/07/23	141.46KB	Share
NXS	Investor Presentation - Q2 2023	PRICE SENSITIVE	27/07/23	1.01MB	Share
NXS	Quarterly Activity Report - 30 June 2023	PRICE SENSITIVE	27/07/23	194.59KB	Share
NXS	Appendix 4C - 30 June 2023	PRICE SENSITIVE	27/07/23	216.77KB	Share
NXS	Letter to shareholders - new Investor Hub		24/07/23	286.71KB	Share
NXS	Appendix 3X - Harry Hall IV (I.V.)		12/07/23	232.89KB	Share
NXS	Change of registered office		06/07/23	158.55KB	Share
NXS	Notification regarding unquoted securities - NXS		05/07/23	25.03KB	Share
NXS	Appendix 3Z - B Hancox		05/07/23	129.74KB	Share
NXS	Director Retirement		30/06/23	160.35KB	Share
NXS	Market Update	PRICE SENSITIVE	29/06/23	163.51KB	Share
NXS	Appointment of new Managing Director and CEO	PRICE SENSITIVE	16/06/23	188.38KB	Share
NXS	2023 AGM - Voting Results		26/05/23	215.65KB	Share
NXS	AGM Chair & Managing Director Addresses		26/05/23	307.04KB	Share
NXS	Quarterly Activity Report 31 March 2023 - Addendum		01/05/23	119.44KB	Share
NXS	Corporate Governance Statement and Appendix 4G		24/04/23	688.26KB	Share
NXS	2023 AGM Notice of Meeting		24/04/23	2.24MB	Share
NXS	2022 Annual Report		24/04/23	17.67MB	Share
NXS	Investor Presentation - Q1 2023	PRICE SENSITIVE	21/04/23	896.74KB	Share
NXS	Quarterly Activity Report - 31 March 2023	PRICE SENSITIVE	21/04/23	191.13KB	Share
NXS	Appendix 4C - 31 March 2023	PRICE SENSITIVE	21/04/23	360.2KB	Share
NXS	Notification of date of 2023 AGM		27/03/23	77.07KB	Share
NXS	Ceasing to be a substantial holder		10/03/23	215.95KB	Share
NXS	FY22 Investor Presentation	PRICE SENSITIVE	28/02/23	856.66KB	Share
NXS	Next Science FY22 Results and FY23 Outlook	PRICE SENSITIVE	28/02/23	158.9KB	Share

NXS Investor presentation
30/04/24		956.25KB	Share
NXS Appendix 4C & Quarterly Activity Report - 31 March 2024
24/04/24	PRICE SENSITIVE	409.47KB	Share
NXS Notice of 1Q FY24 Result and Investor Webinar
22/04/24		123.15KB	Share
NXS Publication of Dr. Harris XPERIENCE study
18/04/24	PRICE SENSITIVE	170.21KB	Share
NXS Preliminary results of further XPERIENCE studies released
17/04/24	PRICE SENSITIVE	172.43KB	Share
NXS Study published showing impact of XPERIENCE on SSIs
16/04/24	PRICE SENSITIVE	168.16KB	Share
NXS Publication of study showing BLASTX increases NPWT efficacy
09/04/24	PRICE SENSITIVE	185.13KB	Share
NXS Appendix 4G & 2024 Corporate Governance Statement
05/04/24		641.02KB	Share
NXS 2023 Annual Report
05/04/24		5.25MB	Share
NXS Notification of cessation of securities - NXS
04/04/24		12.81KB	Share
NXS 2024 AGM - Notice of Meeting
03/04/24		1.86MB	Share
NXS Board Changes
03/04/24		158.74KB	Share
NXS 2024 Annual General Meeting - Notification of dates
04/03/24		117.85KB	Share
NXS FY23 Annual Result Investor Presentation
28/02/24	PRICE SENSITIVE	1.02MB	Share
NXS Next Science reports FY23 Result
28/02/24	PRICE SENSITIVE	186.4KB	Share
NXS Appendix 4E / FY23 Financial Statements
28/02/24	PRICE SENSITIVE	1.14MB	Share
NXS Revised Securities Trading Policy
27/02/24		278.34KB	Share
NXS Notice of FY23 Results and Investor Webinar
16/02/24		125.03KB	Share
NXS Appendix 4C & Quarterly Activity Report - 31 December 2023
30/01/24	PRICE SENSITIVE	324.86KB	Share
NXS Vale Lang Walker AO
29/01/24		173.33KB	Share
NXS Notification of cessation of securities - NXS
12/01/24		21.57KB	Share
NXS Notification of cessation of securities - NXS
12/01/24		21.52KB	Share
NXS XPERIENCE study findings published
22/12/23	PRICE SENSITIVE	168.05KB	Share
NXS Appendix 3Y - A Stockburger
19/12/23		158.78KB	Share
NXS Appendix 3Y - D Spira
19/12/23		158.8KB	Share
NXS Notification of cessation of securities - NXS
19/12/23		21.57KB	Share
NXS Notification of cessation of securities - NXS
19/12/23		21.51KB	Share
NXS Notification of cessation of securities - NXS
08/12/23		22.63KB	Share
NXS NXS Presentation - Bell Potter Healthcare Conference
15/11/23		743.41KB	Share
NXS Response to ASX Aware Letter
07/11/23	PRICE SENSITIVE	785.32KB	Share
NXS XPERIENCE study findings released
03/11/23	PRICE SENSITIVE	179.47KB	Share
NXS Appendix 3Y - I.V. Hall
02/11/23		204.51KB	Share
NXS Appendix 3Y - G Hummel
02/11/23		158.66KB	Share
NXS Appendix 3Y - A Stockburger
02/11/23		158.96KB	Share
NXS Change in substantial holding
02/11/23		347.48KB	Share
NXS Cleansing notice
01/11/23		127.49KB	Share
NXS Application for quotation of securities - NXS
31/10/23		25.38KB	Share
NXS Application for quotation of securities - NXS
31/10/23		23.3KB	Share
NXS Application for quotation of securities - NXS
31/10/23		23.62KB	Share
NXS NXS Presentation - Wilsons Drug & Device Conference
26/10/23		740.01KB	Share
NXS General Meeting - Voting Results
25/10/23		215.89KB	Share
NXS General Meeting - CEO 90 Day Update
25/10/23		226.84KB	Share
NXS Appendix 3X - Kathy Ostin
24/10/23		180.1KB	Share
NXS Appointment of new Director
24/10/23		123.01KB	Share
NXS Investor Presentation - Q3 2023
23/10/23	PRICE SENSITIVE	618.81KB	Share
NXS Quarterly Activity Report - 30 September 2023
23/10/23	PRICE SENSITIVE	176.67KB	Share
NXS Appendix 4C - 30 September 2023
23/10/23	PRICE SENSITIVE	261.2KB	Share
NXS Change in substantial holding
26/09/23		359.95KB	Share
NXS Cleansing notice
25/09/23		117.69KB	Share
NXS Notice of General Meeting
22/09/23		1.29MB	Share
NXS Application for quotation of securities - NXS
22/09/23		23.49KB	Share
NXS Application for quotation of securities - NXS
22/09/23		23.43KB	Share
NXS Successful completion of Share Purchase Plan & US Offer
22/09/23	PRICE SENSITIVE	165.12KB	Share
NXS Becoming a substantial holder
20/09/23		153.19KB	Share
NXS Becoming a substantial holder from TEK
20/09/23		179.19KB	Share
NXS Next Science SPP - ASX grants waiver
07/09/23		181.58KB	Share
NXS Cleansing Notice
06/09/23		117.52KB	Share
NXS Application for quotation of securities - NXS
05/09/23		23.57KB	Share
NXS Next Science SPP - Letter to Eligible Shareholders
01/09/23		143.26KB	Share
NXS Next Science Share Purchase Plan Booklet
01/09/23		236.16KB	Share
NXS Next Science SPP Offer Opens
01/09/23		138.94KB	Share
NXS Half Year Results & Capital Raise Presentation
31/08/23	PRICE SENSITIVE	2.29MB	Share
NXS Cleansing Notice
31/08/23		145.18KB	Share
NXS Proposed issue of securities - NXS
31/08/23		36.42KB	Share
NXS Half Year Report & Appendix 4D
31/08/23	PRICE SENSITIVE	557.76KB	Share
NXS Half Year Results & Capital Raise Update
31/08/23	PRICE SENSITIVE	271.48KB	Share
NXS Trading Halt
29/08/23	PRICE SENSITIVE	138.39KB	Share
NXS Appendix 3Z - M Compton
29/08/23		129.75KB	Share
NXS Appendix 3X - Grant Hummel
28/08/23		180.07KB	Share
NXS Half Year Results Investor Briefing
25/08/23		171.42KB	Share
NXS Board Changes
23/08/23		129.37KB	Share
NXS Potential Anti-Inflammatory Benefit For XPERIENCE
09/08/23	PRICE SENSITIVE	194.97KB	Share
NXS Investor Presentation
08/08/23	PRICE SENSITIVE	1.46MB	Share
NXS Notification regarding unquoted securities - NXS
31/07/23		27.25KB	Share
NXS Notification regarding unquoted securities - NXS
31/07/23		25.54KB	Share
NXS Appendix 3Z - Judith Mitchell
31/07/23		141.46KB	Share
NXS Investor Presentation - Q2 2023
27/07/23	PRICE SENSITIVE	1.01MB	Share
NXS Quarterly Activity Report - 30 June 2023
27/07/23	PRICE SENSITIVE	194.59KB	Share
NXS Appendix 4C - 30 June 2023
27/07/23	PRICE SENSITIVE	216.77KB	Share
NXS Letter to shareholders - new Investor Hub
24/07/23		286.71KB	Share
NXS Appendix 3X - Harry Hall IV (I.V.)
12/07/23		232.89KB	Share
NXS Change of registered office
06/07/23		158.55KB	Share
NXS Notification regarding unquoted securities - NXS
05/07/23		25.03KB	Share
NXS Appendix 3Z - B Hancox
05/07/23		129.74KB	Share
NXS Director Retirement
30/06/23		160.35KB	Share
NXS Market Update
29/06/23	PRICE SENSITIVE	163.51KB	Share
NXS Appointment of new Managing Director and CEO
16/06/23	PRICE SENSITIVE	188.38KB	Share
NXS 2023 AGM - Voting Results
26/05/23		215.65KB	Share
NXS AGM Chair & Managing Director Addresses
26/05/23		307.04KB	Share
NXS Quarterly Activity Report 31 March 2023 - Addendum
01/05/23		119.44KB	Share
NXS Corporate Governance Statement and Appendix 4G
24/04/23		688.26KB	Share
NXS 2023 AGM Notice of Meeting
24/04/23		2.24MB	Share
NXS 2022 Annual Report
24/04/23		17.67MB	Share
NXS Investor Presentation - Q1 2023
21/04/23	PRICE SENSITIVE	896.74KB	Share
NXS Quarterly Activity Report - 31 March 2023
21/04/23	PRICE SENSITIVE	191.13KB	Share
NXS Appendix 4C - 31 March 2023
21/04/23	PRICE SENSITIVE	360.2KB	Share
NXS Notification of date of 2023 AGM
27/03/23		77.07KB	Share
NXS Ceasing to be a substantial holder
10/03/23		215.95KB	Share
NXS FY22 Investor Presentation
28/02/23	PRICE SENSITIVE	856.66KB	Share
NXS Next Science FY22 Results and FY23 Outlook
28/02/23	PRICE SENSITIVE	158.9KB	Share

REFRESH

1 2 3 4 5 6

(20min delay)
Last 32.5¢		Change 0.015(4.84%)		Mkt cap ! $94.80M

Open	High	Low	Value	Volume
31.0¢	32.5¢	31.0¢	$3.532K	11.10K

Buyers (Bids)

No.	Vol.	Price($)
1	3049	31.5¢

Sellers (Offers)

Price($)	Vol.	No.
32.5¢	4394	1

View Market Depth

No.	Vol.	Price($)
1	3049	0.315
5	64283	0.310
1	25000	0.305
1	3333	0.300
2	16800	0.280

Price($)	Vol.	No.
0.325	4394	1
0.345	54296	1
0.360	40000	1
0.365	2739	1
0.370	28075	2

Last trade - 16.10pm 01/05/2024 (20 minute delay)


Last 32.0¢		Change 0.015 ( 1.59 %)
Open	High	Low	Volume
32.0¢	32.5¢	32.0¢	1381
Last updated 15.59pm 01/05/2024 ?

NXS (ASX) Chart

NEXT SCIENCE LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories